Molecular Diagnosis of Systemic Autoinflammatory Diseases

Recruiting now

Conditions studied: Inflammatory Disease, Genetic Disease, Somatic Mutation, Molecular Sequence Variation, Molecular Pathway Deregulation

In brief

Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.

Key facts

Study ID

NCT05364294

Run by

Institut National de la Santé Et de la Recherche Médicale, France

People needed

300

Starts

2022-05-18

Expected to finish

2033-05-02

Last updated by the study team

2026-03-05

Who can join

Age: 0 and older, up to 120. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• A patient presenting with a clinical and biological aseptic inflammatory syndrome associating one or more of the following signs: spontaneously resolving fever, abdominal (pain, diarrhea), locomotor (arthralgia, myalgia), thoracic (pain, pericarditis), cutaneous, sensory (uveitis, deafness), or renal (amyloidosis) involvement.

You may not qualify if…

• Adult subject to legal protection measures (guardianship, curatorship, safeguard of justice).

Where it is running

• Trousseau Hospital — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.